. . . . . . . . . . . . . . . "a(CHEBI:gefitinib) =| kin(p(HGNC:EGFR))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "EGFR Iressa (ZD1839) Phase III treatment (182) Preclinical prevention (183,184) Tarceva OSI774) Phase III treatment (185,186) PKI-166 Phase I treatment (187, 188) CI-1033 Phase II treatment (189-192) EKB-569 Phase I treatment (189-192) GW502016 Phase I treatment (187, 188) Way177-820 Preclinical development (193) GW572016 Preclinical development (193)" . . "Selventa" . . . . "2014-07-03T14:30:17.899+02:00"^^ . . .